Waters Corporation (NYSE:WAT) Stock Has Consensus Target Price of $475.48 According to Brokerages

Shares of Waters Corporation (NYSE:WAT – Get Free Report) have been assigned an average rating of “Moderate Buy” from the twenty-four research firms that are presently covering the firm, MarketBeat Ratings reports. Six analysts have rated the stock with a hold recommendation, seventeen have given a buy recommendation and one has given a strong buy recommendation to the company. The average 12-month target price among analysts that have issued a report on the stock in the last year is $475.48.

A number of analysts have commented on the company. Stifel Nicolaus set a $470.00 price target on Waters in a research report on Wednesday, November 4th. Morgan Stanley set a $430.00 price objective on Waters in a report on Wednesday, August 5th. Wells Fargo & Company increased their price objective on Waters from $370.00 to $400.00 and gave the company an “equal weight” rating in a report on Wednesday, August 5th. Robert W. Baird raised their price objective on Waters from $456.00 to $495.00 and gave the stock an “outperform” rating in a research note on Thursday, October 8th. Finally, Piper Sandler raised Waters from a “neutral” rating to an “overweight” rating and lifted their target price for the stock from $400.00 to $480.00 in a report on Thursday, August 27th.

View Our Latest Research Report on Waters

Institutional Investors Weigh In On Waters

Several large investors have recently bought and sold shares of WAT. California Public Employees Retirement System grew its stake in Waters by 25.4% during the first quarter. California Public Employees Retirement System now owns 138,423 shares of the medical instruments supplier’s stock worth $41,222,000 after buying an additional 28,074 shares during the period. Dudley & Shanley Inc. raised its stake in shares of Waters by 101.3% in the 2nd quarter. Dudley & Shanley Inc. now owns 23,590 shares of the medical instruments supplier’s stock valued at $8,847,000 after acquiring an additional 11,870 shares during the period. Handelsbanken Fonder AB raised its stake in shares of Waters by 93.1% in the 2nd quarter. Handelsbanken Fonder AB now owns 93,653 shares of the medical instruments supplier’s stock valued at $35,124,000 after acquiring an additional 45,145 shares during the period. OVERSEA CHINESE BANKING Corp Ltd increased its holdings in Waters by 18.4% in the 2nd quarter. OVERSEA CHINESE BANKING Corp Ltd now owns 95,028 shares of the medical instruments supplier’s stock valued at $35,639,000 after purchasing an additional 14,754 shares in the last quarter. Finally, Hikari Power Ltd acquired a new stake in Waters in the 2nd quarter valued at $1,793,000. 94.01% of the stock is currently owned by hedge funds and other institutional investors.

Waters Price Performance

Shares of WAT stock opened at $439.73 on Wednesday. Waters has a twelve month low of $282.77 and a twelve month high of $483.33. The stock has a market capitalization of $43.22 billion, a price-to-earnings ratio of 188.73, a P/E/G ratio of 2.58 and a beta of 1.16. The stock has a fifty day simple moving average of $445.18 and a two-hundred day simple moving average of $376.00. The company has a current ratio of 1.89, a quick ratio of 1.28 and a debt-to-equity ratio of 0.29.

Waters (NYSE:WAT – Get Free Report) last posted its earnings results on Tuesday, November 3rd. The medical instruments supplier reported $4.10 EPS for the quarter, beating analysts’ consensus estimates of $4.00 by $0.10. Waters had a net margin of 1.75% and a return on equity of 9.91%. The business had revenue of $1.77 billion for the quarter, compared to the consensus estimate of $1.75 billion. During the same quarter last year, the firm posted $3.40 EPS. The company’s revenue for the quarter was up 120.9% on a year-over-year basis. On average, analysts predict that Waters will post 14.65 EPS for the current fiscal year.

About Waters

(Get Free Report)

Waters Corporation develops and supplies analytical instruments, software, and consumables used to identify, measure, and characterize chemical and biological materials. Its products include liquid chromatography and mass spectrometry systems, which help customers analyze complex samples. The company serves pharmaceutical and biotechnology businesses, academic and government laboratories, and customers in fields such as food, environmental testing, and materials science. Waters operates internationally, with customers and operations across multiple regions.

Read More

Analyst Recommendations for Waters (NYSE:WAT)

Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.